Showing 1 - 20 results of 16,124 for search '(( 59 ((_ decrease) OR (a decrease)) ) OR ((( _ web decrease ) OR ( 100 years decrease ))))*', query time: 0.59s Refine Results
  1. 1

    Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

    Published 2018
    “…<p></p><p>Abstract Purpose: To demonstrate the efficacy of 0.025% atropine eyedrops in myopic children in Brazil for decreasing myopia progression Methods: This was a prospective study with 60 children from Hospital Geral Universitário and Oftalmocenter Santa Rosa in Cuiabá, MT, Brazil, aged between 6 to 12 years, with spherical equivalent refractive error of -1.00 to -6.00 diopters (D) and astigmatism of -1.00 D or smaller. …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Supplementary Material for: Kidney and cardiovascular outcomes in older population with mildly to moderately decreased kidney function - A nationwide cohort study by Jeon J. (10323467)

    Published 2024
    “…We investigated the clinical outcomes in older populations with mildly to moderately decreased GFR (45–59 ml/min/1.73 m2, CKD stage 3A). …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Image_1_Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study.jpeg by Gabriella Liszkay (10135301)

    Published 2021
    “…The change of incidence trends (2011–2015 vs. 2015–2019) was significant in females (p=0.002) and in the total melanoma population (p=0.011), but not in the male population (p=0.063). A 16.55% (95% CI: −27.07 to −4.59; p=0.013) decrease in mortality rates was found in the overall melanoma population.…”
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    DataSheet_1_Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study.docx by Gabriella Liszkay (10135301)

    Published 2021
    “…The change of incidence trends (2011–2015 vs. 2015–2019) was significant in females (p=0.002) and in the total melanoma population (p=0.011), but not in the male population (p=0.063). A 16.55% (95% CI: −27.07 to −4.59; p=0.013) decrease in mortality rates was found in the overall melanoma population.…”
  20. 20